Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | FABP4 | P15090 | 1/20 | 0.50 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.50 |
| ▸ | GLS | O94925 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29639215 | 1.00 | KMT2A (0.54) | KMT2AMEN1KDM4EALDH1A1HSD17B10 | |
| Hydrochloric Acid SCHEMBL2532791 | 0.98 | KMT2A (0.55) | KMT2AMEN1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL11121247 | 0.89 | HTT (0.51) | KMT2AMEN1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL9079419 | 0.89 | AKR1B1 (0.52) | KMT2AMEN1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL2875253 | 0.87 | MAPK1 (0.47) | KMT2AMEN1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL10714737 | 0.86 | KMT2A (0.55) | KMT2AMEN1KDM4EALDH1A1HIF1A | |
| SCHEMBL2586902 | 0.86 | CYP3A4 (0.53) | KMT2AMEN1KDM4EALDH1A1HIF1A | |
| SCHEMBL6964064 | 0.86 | KMT2A (0.50) | KMT2AMEN1KDM4EALDH1A1HIF1A | |
| SCHEMBL11173910 | 0.85 | MEN1 (0.53) | KMT2AMEN1ALDH1A1HSD17B10HIF1A | |
| SCHEMBL2532788 | 0.84 | KMT2A (0.49) | KMT2AMEN1KDM4EALDH1A1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110669402-B | 3D printing coating and preparation method thereof | 炫杰复合材料（上海）有限公司 | 2021-11-26 | — | — | CN | claimed |
| CN-110669403-B | Self-adhesive surface-mounted coating and preparation method thereof | 炫杰复合材料（上海）有限公司 | 2021-09-14 | — | — | CN | claimed |
| CN-110669403-A | Self-adhesive surface-mounted coating and preparation method thereof | 炫杰复合材料（上海）有限公司 | 2020-01-10 | — | — | CN | claimed |
| CN-110669402-A | 3D printing coating and preparation method thereof | 炫杰复合材料（上海）有限公司 | 2020-01-10 | — | — | CN | claimed |
| CN-106810593-B | A kind of tanshinone compound 17-position ester derivative and its preparation process and application | 郑州大学 | 2018-12-04 | — | — | CN | claimed |
| CN-103965109-B | A kind of method of synthesizing codamine | ANTI-DRUG INFORMATION TECHNOLOGY CENTER OF THE MINISTRY OF PUBLIC SECURITY (CN) | 2015-08-19 | — | — | CN | claimed |
| EP-2448913-B1 | CONTINUOUS METHOD FOR ACYLATING AMINO GROUP-CARRYING ORGANIC ACIDS | CLARIANT FINANCE BVI LTD (VG) | 2013-04-24 | — | — | EP | claimed |
| EP-2448913-A2 | CONTINUOUS METHOD FOR ACYLATING AMINO GROUP-CARRYING ORGANIC ACIDS | Clariant Finance (BVI) Limited (VG) | 2012-05-09 | — | — | EP | claimed |
| US-20120090983-A1 | Continuous Method For Acylating Amino Group-Carrying Organic Acids | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-04-19 | — | — | US | claimed |
| WO-2011000461-A2 | CONTINUOUS METHOD FOR ACYLATING AMINO GROUP-CARRYING ORGANIC ACIDS | CLARIANT INTERNATIONAL LTD (CH) | 2011-01-06 | — | — | WO | claimed |
| US-6451334-B2 | PULSE ADMINISTERING OF A C1-C4 SUBSTITUTED AND/OR PHENYL SUBSTITUTED CARBOXYLIC ACID AND SALTS AND A CARRIER OR DILUENT TO STIMULATE CELLS IN TREATING BLOOD DISORDERS, E.G. SICKLE CELL ANEMIA, THALASSEMIA, BLOOD LOSS ETC. | Perrine, Susan P. | 2002-09-17 | — | — | US | claimed |
| WO-2025202300-A1 | COMPLEX COACERVATES FOR NUTRACEUTICALS | NEKTIUM PHARMA S.L. (ES) | 2025-10-02 | — | — | WO | disclosed |
| EP-4623703-A1 | COMPLEX COACERVATES FOR NUTRACEUTICALS | Nektium Pharma S.L. (ES) | 2025-10-01 | — | — | EP | disclosed |
| CN-116239561-A | Benzofluorene photochromic compound and application thereof | 上海甘田光学材料有限公司 | 2023-06-09 | — | — | CN | disclosed |
| US-11518768-B2 | Artificial metalloenzymes containing noble metal-porphyrins | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-12-06 | — | — | US | disclosed |
| EP-0474767-B1 | DOPAMINE AGONISTS | ABBOTT LAB (US) | 1996-02-21 | — | — | EP | disclosed |
| EP-0474767-A4 | DOPAMINE AGONISTS | — | 1992-07-08 | — | — | EP | disclosed |
| EP-0474767-A1 | DOPAMINE AGONISTS. | ABBOTT LAB (US) | 1992-03-18 | — | — | EP | disclosed |
| WO-1990015056-A1 | DOPAMINE AGONISTS | ABBOTT LABORATORIES (US) | 1990-12-13 | — | — | WO | disclosed |
| EP-0262953-A2 | Heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1988-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11518768-B2 | Artificial metalloenzymes containing noble metal-porphyrins | PPIH, HMBS, PPOX | KMT2A 1549/4885MEN1 1849/4885KDM4E 2382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.